Natural History Study of Individuals With Androgen Insensitivity
This study is looking at the health and well-being of people with Androgen Insensitivity Syndrome (AIS). AIS is a rare condition where the body doesn't properly respond to male hormones (androgens). Researchers want to understand how AIS affects different aspects of health, including metabolism, bone health, and the risk of tumor formation. They also want to learn more about sexual function and overall quality of life for individuals with AIS. The study aims to gather information from 650 participants aged 8 to 99 years old who have a confirmed diagnosis of AIS. This is an observational study, meaning researchers will collect information over time without giving any specific treatments.
- Study design
- This is an observational study aiming to enroll 650 participants. It is a natural history study, meaning researchers will observe participants over time without providing specific interventions.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Information will be collected until the end of the study, but the specific duration of follow-up for individual participants is not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen Insensitivity
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Veronica Gomez-Lobo, M.D. · PRINCIPAL_INVESTIGATOR · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To define and describe a comprehensive phenotype in 500 patients with androgen insensitivityEnd of study
Primary Objectives: To define and describe a comprehensive phenotype of patients with androgen insensitivity (based on confirmed androgen receptor (AR) gene difference), including hormonal, metabolic, immunologic, and cardiovascular aspects of the disease, as well as quality life and tumor formation risk and evaluation